Characterizing Health Associated Risks, and Your Baseline Disease In SARS-COV-2 (CHARYBDIS)
=============
<h2>PLEASE NOTE: All results are preliminary and subject to change</h2>

**Objectives:**<br>
1) Describe the baseline demographic, clinical characteristics, treatments and outcomes of interest among individuals tested for SARS-CoV-2 and/or diagnosed with COVID-19 overall and stratified by sex, age and specific comorbidities;<br>
2) Describe characteristics and outcomes of patients diagnosed/tested positive for influenza as well as patients hospitalized with influenza between September 2017 and April 2018 compared to the COVID-19 population.<br>

**Resources:**<br>
- The study protocol is available <a href="https://github.com/ohdsi-studies/Covid19CharacterizationCharybdis/blob/master/documents/Protocol_COVID-19%20Charybdis%20Characterisation_V5.docx" target="_blank">here</a>
- All analytic code is availble at <a href="https://github.com/ohdsi-studies/Covid19CharacterizationCharybdis" target="_blank">GitHub</a>